SAB Biotherapeutics Inc
Stock Chart, Company Information, and Scan Results
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
SAB Biotherapeutics Inc Company Information, Fundamentals, and Technical Indicators
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
SAB Biotherapeutics Inc In Our Stock Scanner
As of Jun 16, 2026Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.